Clinical Trial Update: A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing HB1801 with Taxotere (docetaxel) in advanced breast cancer is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HB1801
• Taxotere (docetaxel)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Advanced Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING